Inter-firm R&D networks: the importance of strategic network capabilities for high-tech partnership formation

J. Hagedoorn*, A.H.W.M. Roijakkers, H.L. van Kranenburg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We examine the role of different network capabilities of companies that influence the formation of r&d partnerships in pharmaceutical biotechnology. Strategic network capabilities, specifically centrality-based capabilities and the efficiency with which companies choose their partners, are found to facilitate the formation of new partnerships. Unlike general experience with partnering, these strategic network capabilities play a crucial role in enabling companies to continue to interact with other companies through partnerships in a complex network setting.
Original languageEnglish
Pages (from-to)39-53
JournalBritish Journal of Management
Volume17
DOIs
Publication statusPublished - 1 Jan 2006

Fingerprint

Dive into the research topics of 'Inter-firm R&D networks: the importance of strategic network capabilities for high-tech partnership formation'. Together they form a unique fingerprint.

Cite this